Influence of anti-interleukin (IL)-5/anti-IL-5 receptor-α treatment on work productivity in patients with severe eosinophilic asthma

Nora Drick; Lina Brinkmann; Jan Fuge; Tobias Welte; Hendrik Suhling

doi:10.1183/23120541.00665-2022

Influence of anti-interleukin (IL)-5/anti-IL-5 receptor-α treatment on work productivity in patients with severe eosinophilic asthma

ERJ Open Res. 2023 May 2;9(3):00665-2022. doi: 10.1183/23120541.00665-2022. eCollection 2023 Jul.

Authors

Nora Drick^{1

2}, Lina Brinkmann¹, Jan Fuge^{1

2}, Tobias Welte^{1

2}, Hendrik Suhling^{1

2}

Affiliations

¹ Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
² Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.

Abstract

This retrospective study shows that treatment with anti-eosinophilic antibodies in patients with severe eosinophilic asthma is associated with an increase in work productivity and a decrease in missed days at work https://bit.ly/3IIPppR.